Simian foamy virus infection in humans: Prevalence and management

Expert Review of Anti-Infective Therapy

Volumn 7, Issue 5, 2009, Pages 569-580

  Khan, Arifa S ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Cross species retrovirus; Nonhuman primate; Persistent human infection; Simian foamy virus; Transmission

Indexed keywords

CLINICAL PROTOCOL; DISEASE MODEL; HUMAN; INFECTION PREVENTION; INFECTION RISK; NONHUMAN; PATHOGENICITY; PHYLOGENY; PREVALENCE; PROTECTION; RETROVIRUS; RETROVIRUS INFECTION; REVIEW; RISK REDUCTION; SIMIAN FOAMY VIRUS; SIMIAN FOAMY VIRUS INFECTION; VIRAL GENETICS; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS ISOLATION; VIRUS LATENCY; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSMISSION; ANIMAL; ANIMAL DISEASE; CLASSIFICATION; DISEASE TRANSMISSION; GENETICS; PRIMATE; PRIMATE DISEASE; SPECIES DIFFERENCE; VIROLOGY; ZOONOSIS;

ANIMALS; HUMANS; PHYLOGENY; PRIMATE DISEASES; PRIMATES; RETROVIRIDAE INFECTIONS; SIMIAN FOAMY VIRUS; SPECIES SPECIFICITY; ZOONOSES;

EID: 68249155445     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/ERI.09.39     Document Type: Review

References (131)

1. Linial ML, Fan H, Hahn B et al. Retroviruses. In: Virus Taxonomy: Classification and Nomenclature of Viruses, 8th Repport of the International Committee of the Taxonomy of Viruses. Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA (Eds). Elsevier/Academic Press, London, UK (2005).
2. Rethwilm A. Foamy viruses. In: Topley & Wilson's Microbiology & Microbial Infections. Mahy B, Muelen VT (Eds). Arnold, London, UK, 1304-1321 (2005). • Provides an overview of foamy virus (FV) genome structure and a description of its viral proteins and their functions.
3. Vogt VM. Retroviral Virions and Genomes. Coffin JM, Hughes SH, Varmus HE (Eds). Cold Spring Harbor Laboratory Press, NY, USA (1997).
4. Linial M. Foamy viruses. In: Field's Virology. Knipe DM, Howley PM (Eds). Lippincott Williams & Wilkins, MD, USA, 2245-2262 (2007).
5. Rethwilm A. Regulation of foamy virus gene expression. Curr. Top. Microbiol. Immunol. 193, 1-24 (1995).
6. Zou JX, Luciw PA. The transcriptional transactivator of simian foamy virus 1 binds to a DNA target element in the viral internal promoter. Proc. Natl Acad. Sci. USA 93(1), 326-330 (1996).
7. Muranyi W, Flugel RM. Analysis of splicing patterns of human spumaretrovirus by polymerase chain reaction reveals complex RNA structures. J. Virol. 65, 727-735 (1991).
8. Meiering CD, Linial ML. Historical perspective of foamy virus epidemiology and infection. Clin. Microbiol. Rev. 14(1), 165-176 (2001). •• Provides a comprehensive review of FVs in nonhuman primates (NHPs), its biological properties and experimental models.
9. Mergia A, Luciw PA. Replication and regulation of primate foamy viruses. Virology 184(2), 475-482 (1991).
10. Rethwilm A. Unexpected replication pathways of foamy viruses. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13(Suppl. 1), S248-S253 (1996). (Pubitemid 126735352)
11. Lochelt M. Foamy virus transactivation and gene expression. Curr. Top. Microbiol. Immunol. 277, 27-61 (2003). • Provides details of the regulation of FV replication and transcription. (Pubitemid 36612740)
12. Meiering CD, Linial ML. Reactivation of a complex retrovirus is controlled by a molecular switch and is inhibited by a viral protein. Proc. Natl Acad. Sci. USA 99(23), 15130-15135 (2002).
13. Saïb A, Koken MH, van der Spek P, Périès J, de Thé H. Involvement of a spliced and defective human foamy virus in the establishment of chronic infection. J. Virol. 69(9), 5261-5268 (1995).
14. Saib A, Neves M, Giron ML et al. Long-term persistent infection of domestic rabbits by the human foamy virus. Virology 228(2), 263-268 (1997). •• Demonstration of the role of Bet in FV persistence and latency. (Pubitemid 27238793)
15. Lecellier CH, Saib A. Foamy viruses: between retroviruses and pararetroviruses. Virology 271(1), 1-8 (2000).
16. Linial ML. Foamy viruses are unconventional retroviruses. J. Virol. 73(3), 1747-1755 (1999).
17. Rethwilm A. The replication strategy of foamy viruses. Curr. Top. Microbiol. Immunol. 277, 1-26 (2003).
18. Moebes A, Enssle J, Bieniasz PD et al. Human foamy virus reverse transcription that occurs late in the viral replication cycle. J. Virol. 71(10), 7305-7311 (1997). (Pubitemid 27391668)
19. Yu SF, Sullivan MD, Linial ML. Evidence that the human foamy virus genome is DNA. J. Virol. 73(2), 1565-1572 (1999).
20. Yu SF, Baldwin DN, Gwynn SR, Yendapalli S, Linial ML. Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science 271(5255), 1579-1582 (1996). (Pubitemid 26097215)
21. Delelis O, Saib A, Sonigo P. Biphasic DNA synthesis in spumaviruses. J. Virol. 77(14), 8141-8146 (2003).
22. Flint L, Enquist W, Racaniello VR, Skalka AM. Principles of Virology. ASM Press, DC, USA (2004).
23. Mergia A, Leung NJ, Blackwell J. Cell tropism of the simian foamy virus type 1 (SFV-1). J. Med. Primatol. 25(1), 2-7 (1996). (Pubitemid 126460224)
24. Khan AS, Sears JF, Muller J, Galvin TA, Shahabuddin M. Sensitive assays for isolation and detection of simian foamy retroviruses. J. Clin. Microbiol. 37(8), 2678-2686 (1999). (Pubitemid 29337298)
25. Hooks JJ, Gibbs CJ Jr. The foamy viruses. Bacteriol. Rev. 39(3), 169-185 (1975).
26. Neumann-Haefelin D, Fleps U, Renne R, Schweizer M. Foamy viruses. Intervirology 35(1-4), 196-207 (1993).
27. Saib A. Non-primate foamy viruses. Curr. Top. Microbiol. Immunol. 277, 197-211 (2003).
28. Yu SF, Stone J, Linial ML. Productive persistent infection of hematopoietic cells by human foamy virus. J. Virol. 70(2), 1250-1254 (1996). (Pubitemid 26029051)
29. Falcone V, Schweizer M, Neumann-Haefelin D. Replication of primate foamy viruses in natural and experimental hosts. Curr. Top. Microbiol. Immunol. 277, 161-180 (2003). •• Provides an extensive review of FV infection in natural hosts and experimental studies. (Pubitemid 36612745)
30. Schmidt M, Niewiesk S, Heeney J, Aguzzi A, Rethwilm A. Mouse model to study the replication of primate foamy viruses. J. Gen. Virol. 78(Pt 8), 1929-1933 (1997).
31. Aguzzi A, Marino S, Tschopp R, Rethwilm A. Regulation of expression and pathogenic potential of human foamy virus in vitro and in transgenic mice. Curr. Top. Microbiol. Immunol. 206, 243-273 (1996). (Pubitemid 26025612)
32. Brooks JI, Merks HW, Fournier J, Boneva RS, Sandstrom PA. Characterization of blood-borne transmission of simian foamy virus. Transfusion 47(1), 162-170 (2007). • Demonstrates FV transmission by blood in a monkey model. (Pubitemid 46006324)
33. Khan AS, Kumar D. Simian foamy virus infection by whole-blood transfer in rhesus macaques: potential for transfusion transmission in humans. Transfusion 46(8), 1352-1359 (2006). • Demonstrates FV infection by blood transfusion in a monkey model and the potential role of neutralizing antibodies in virus transmission. (Pubitemid 44117963)
34. Hooks JJ, Detrick-Hooks B. Simian foamy virus-induced immunosuppression in rabbits. J. Gen. Virol. 44(2), 383-390 (1979). (Pubitemid 10234772)
35. Johnston PB. Studies on simian foamy viruses and syncytium-forming viruses of lower animals. Lab. Anim. Sci. 24(1), 159-166 (1974).
36. Swack NS, Hsiung GD. Pathogenesis of simian foamy virus infection in natural and experimental hosts. Infect. Immun. 12(3), 470-474 (1975).
37. Santillana-Hayat M, Rozain F, Bittoun P et al. Transient immunosuppressive effect induced in rabbits and mice by the human spumaretrovirus prototype HFV (human foamy virus). Res. Virol. 144(5), 389-396 (1993). (Pubitemid 23319734)
38. Brown P, Moreau-Dubois MC, Gajdusek DC. Persistent asymptomatic infection of the laboratory mouse by simian foamy virus type 6: a new model of retrovirus latency. Arch. Virol. 71(3), 229-234 (1982). (Pubitemid 12072657)
39. Falcone V, Leupold J, Clotten J et al. Sites of simian foamy virus persistence in naturally infected African green monkeys: latent provirus is ubiquitous, whereas viral replication is restricted to the oral mucosa. Virology 257(1), 7-14 (1999). •• Evalautes FV persistence, latency and expression in monkeys and demonstrates the potential for its transmission via saliva. (Pubitemid 29391795)
40. Murray SM, Picker LJ, Axthelm MK, Linial ML. Expanded tissue targets for foamy virus replication with simian immunodeficiency virus-induced immunosuppression. J. Virol. 80(2), 663-670 (2006). •• Demonstrates that FV and SIV coinfection studies in monkeys may aid in evaluating consequences of dual infection in HIV-1-infected humans.
41. Murray SM, Picker LJ, Axthelm MK, Hudkins K, Alpers CE, Linial ML. Replication in a superficial epithelial cell niche explains the lack of pathogenicity of primate foamy virus infections. J. Virol. 82(12), 5981-5985 (2008). •• Demonstrates mode of FV transmission via saliva in monkeys. (Pubitemid 351822271)
42. Switzer WM, Bhullar V, Shanmugam V et al. Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates. J. Virol. 78(6), 2780-2789 (2004). •• Comprehensive evaluation of FV transmissions due to occupational exposure with an identification of the species of origin. (Pubitemid 38314337)
43. Boneva RS, Switzer WM, Spira TJ et al. Clinical and virological characterization of persistent human infection with simian foamy viruses. AIDS Res. Hum. Retroviruses 23(11), 1330-1337 (2007). • Long-term follow-up of human infections demonstrating the absence of FV-associated disease.
44. Callahan ME, Switzer WM, Matthews AL et al. Persistent zoonotic infection of a human with simian foamy virus in the absence of an intact orf-2 accessory gene. J. Virol. 73(11), 9619-9624 (1999).
45. Calattini S, Betsem EB, Froment A et al. Simian foamy virus transmission from apes to humans, rural Cameroon. Emerg. Infect. Dis. 13(9), 1314-1320 (2007). • Evaluates FV transmission in natural settings in Africa and demonstrates a higher infection rate by apes than monkeys. (Pubitemid 47515264)
46. Heneine W, Schweizer M, Sandstrom P, Folks T. Human infection with foamy viruses. Curr. Top. Microbiol. Immunol. 277, 181-196 (2003).
47. Linial M. Why aren't foamy viruses pathogenic? Trends Microbiol. 8(6), 284-289 (2000). (Pubitemid 30331003)
48. Heneine W, Switzer WM, Sandstrom P et al. Identification of a human population infected with simian foamy viruses. Nat. Med. 4(4), 403-407 (1998). (Pubitemid 28212754)
49. Jones-Engel L, Engel GA, Schillaci MA et al. Primate-to-human retroviral transmission in Asia. Emerg. Infect. Dis. 11(7), 1028-1035 (2005).
50. Neumann-Haefelin D, Rethwilm A, Bauer G, Gudat F, zur Hausen H. Characterization of a foamy virus isolated from Cercopithecus aethiops lymphoblastoid cells. Med. Microbiol. Immunol. 172(2), 75-86 (1983).
51. Sandstrom PA, Phan KO, Switzer WM et al. Simian foamy virus infection among zoo keepers. Lancet 355(9203), 551-552 (2000).
52. Brooks JI, Rud EW, Pilon RG, Smith JM, Switzer WM, Sandstrom PA. Cross-species retroviral transmission from macaques to human beings. Lancet 360 (9330), 387-388 (2002).
53. Gessain A, Calattini S. Emergence of simian foamy viruses in humans: facts and unanswered questions. Future Virol. 3, 71-81 (2008). • Review of FV transmissions, especially in natural settings.
54. Switzer WM, Salemi M, Shanmugam V et al. Ancient co-speciation of simian foamy viruses and primates. Nature 434(7031), 376-380 (2005). •• Demonstration that FVes are ancient retroviruses of NHPs. (Pubitemid 40469179)
55. Polavarapu N, Bowen NJ, McDonald JF. Identification, characterization and comparative genomics of chimpanzee endogenous retroviruses. Genome Biol. 7(6), R51 (2006). (Pubitemid 43986011)
56. Polavarapu N, Bowen NJ, McDonald JF. Newly identified families of human endogenous retroviruses. J. Virol. 80(9), 4640-4642 (2006).
57. Boeke JD, Stoye JP. Retrotransposons, Endogenous Retroviruses, and the Evolution of Retroelements. Coffin JM, Hughes SH, Varmus HE (Eds). Cold Spring Harbor Laboratory Press, NY, USA (1997).
58. Weiss RA. The discovery of endogneous retroviruses. Retrovirology 3, 67 (2006). • Review of the generation of pathogenic retroviruses by recombination.
59. Weiss RA. Lessons from naked apes and their infections. J. Med. Primatol. 36, 172-179 (2007).
60. Delebecque F, Suspene R, Calattini S et al. Restriction of foamy viruses by APOBEC cytidine deaminases. J. Virol. 80(2), 605-614 (2006). (Pubitemid 43062873)
61. Perkovic M, Schmidt S, Marino D et al. Species-specific inhibition of APOBEC3C by the prototype foamy virus protein Bet. J. Biol. Chem. 284(9), 5819-5826 (2009).
62. Lecellier CH, Dunoyer P, Arar K et al. A cellular microRNA mediates antiviral defense in human cells. Science 308(5721), 557-560 (2005). (Pubitemid 40570587)
63. Yap MW, Lindemann D, Stanke N et al. Restriction of foamy viruses by primate Trim5a. J. Virol. 82(11), 5429-5439 (2008). (Pubitemid 351705250)
64. Lochelt M, Romen F, Bastone P et al. The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. Proc. Natl Acad. Sci. USA 102(22), 7982-7987 (2005). (Pubitemid 40781049)
65. Russell RA, Wiegand HL, Moore MD, Schafer A, McClure MO, Cullen BR. Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. J. Virol. 79(14), 8724-8731 (2005). (Pubitemid 40934783)
66. Perkovic M, Schmidt S, Marino D et al. Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet. J. Biol. Chem. 284(9), 5819-5826 (2009).
67. Saib A, Peries J, de The H. A defective human foamy provirus generated by pregenome splicing. EMBO J. 12(11), 4439-4444 (1993). (Pubitemid 23302059)
68. Asquith B, Bangham CR. Quantifying HTLV-I dynamics. Immunol. Cell Biol. 85(4), 280-286 (2007).
69. Enders JF, Peebles TC. Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc. Soc. Exp. Biol. Med. 86(2), 277-286 (1954).
70. Murphy HW, Miller M, Ramer J et al. Implications of simian retroviruses for captive primate population management and the occupational safety of primate handlers. J. Zoo Wildl. Med. 37(3), 219-233 (2006). •• Discussion of simian retroviruses in NHPs and measures for the safety of primate handlers. (Pubitemid 44521187)
71. Switzer WM, Garcia AD, Yang C et al. Co-infection with HIV-1 and simian foamy virus in west central Africans. J. Infect. Dis. 197(10), 1389-1393 (2008). •• First report of FV infections in HIV-1- infected individuals. (Pubitemid 351706462)
72. Jones-Engel L, Steinkraus KA, Murray SM et al. Sensitive assays for simian foamy viruses reveal a high prevalence of infection in commensal, free-ranging Asian monkeys. J. Virol. 81(14), 7330-7337 (2007). (Pubitemid 47047822)
73. Swack NS. Infections by foamy viruses. In: CRC Handbook Series in Zoonoses: Viral Zoones. Beran GW (Ed.). CRC Press, FL, USA, 282-288 (1981).
74. Calattini S, Wanert F, Thierry B et al. Modes of transmission and genetic diversity of foamy viruses in a Macaca tonkeana colony. Retrovirology 3, 23 (2006). (Pubitemid 44219122)
75. Blewett EL, Black DH, Lerche NW, White G, Eberle R. Simian foamy virus infections in a baboon breeding colony. Virology 278(1), 183-193 (2000). (Pubitemid 32002606)
76. Broussard SR, Comuzzie AG, Leighton KL, Leland MM, Whitehead EM, Allan JS. Characterization of new simian foamy viruses from African nonhuman primates. Virology 237(2), 349-359 (1997).
77. Hussain AI, Shanmugam V, Bhullar VB et al. Screening for simian foamy virus infection by using a combined antigen western blot assay: evidence for a wide distribution among Old World primates and identification of four new divergent viruses. Virology 309(2), 248-257 (2003). (Pubitemid 36579219)
78. Liu W, Worobey M, Li Y et al. Molecular ecology and natural history of simian foamy virus infection in wild-living chimpanzees. PLoS Pathog. 4(7), e1000097 (2008).
79. Jones-Engel L, Engel GA, Heidrich J et al. Temple monkeys and health implications of commensalism, Kathmandu, Nepal. Emerg. Infect. Dis. 12(6), 900-906 (2006). (Pubitemid 43848410)
80. Achong BG, Mansell PW, Epstein MA. A new human virus in cultures from a nasopharyngeal carcinoma. J. Pathol. 103(2), P18 (1971).
81. Achong BG, Mansell PW, Epstein MA, Clifford P. An unusual virus in cultures from a human nasopharyngeal carcinoma. J. Natl Cancer Inst. 46(2), 299-307 (1971).
82. Linial M, Fan H, Hahn B et al. Retroviridae. In: Virus Taxonomy, 8th Report of the ICTV. Faquet CM, Mayo MA, Maniloff J et al. (Eds). Elsevier/Academic Press, London, UK, 421-440 (2004).
83. Schweizer M, Turek R, Hahn H et al. Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res. Hum. Retroviruses 11(1), 161-170 (1995).
84. Ali M, Taylor GP, Pitman RJ et al. No evidence of antibody to human foamy virus in widespread human populations. AIDS Res. Hum. Retroviruses 12(15), 1473-1483 (1996). (Pubitemid 26341540)
85. Jones-Engel L, May CC, Engel GA et al. Diverse contexts of zoonotic transmission of simian foamy viruses in Asia. Emerg. Infect. Dis. 14(8), 1200-1208 (2008). •• Describes unique concerns regarding FV transmissions in natural settings in Asia.
86. Wolfe ND, Switzer WM, Carr JK et al. Naturally acquired simian retrovirus infections in central African hunters. Lancet 363(9413), 932-937 (2004). • First report of FV infection in a natural setting in hunters in Africa
87. Schweizer M, Falcone V, Gange J, Turek R, Neumann-Haefelin D. Simian foamy virus isolated from an accidentally infected human individual. J. Virol. 71(6), 4821-4824 (1997). (Pubitemid 27204177)
88. Hill CL, Bieniasz PD, McClure MO. Properties of human foamy virus relevant to its development as a vector for gene therapy. J. Gen. Virol. 80(Pt 8), 2003-2009 (1999).
89. Muller HK, Ball G, Epstein MA, Achong BG, Lenoir G, Levin A. The prevalence of naturally occurring antibodies to human syncytial virus in East African populations. J. Gen. Virol. 47(2), 399-406 (1980). (Pubitemid 10092473)
90. Achong BG, Epstein MA. Preliminary seroepidemiological studies on the human syncytial virus. J. Gen. Virol. 40, 175-181 (1978).
91. Achong BG, Epstein MA. Naturally occurring antibodies to the human syncytial virus in west Africa. J. Med. Virol. 11(1), 53-57 (1983).
92. Schillaci MA, Jones-Engel L, Engel GA et al. Prevalence of enzootic simian viruses among urban performance monkeys in Indonesia. Trop. Med. Int. Health 10(12), 1305-1314 (2005). (Pubitemid 41789685)
93. Fuentes A. Human culture and monkey behavior: assessing the contexts of potential pathogen transmission between macaques and humans. Am. J. Primatol. 68(9), 880-896 (2006). (Pubitemid 44337981)
94. Wolfe ND. Bushmeat hunting, deforestation, and prediction of zoonotic disease emergence. Emerg. Infect. Dis. 11(12), 1822-1827 (2005).
95. Weiss RA. Retroviral zoonoses. Nat. Med. 4(4), 391-392 (1998).
96. Wolfe ND, Dunavan CP, Diamond J. Origins of major human infectious diseases. Nature 447(7142), 279-283 (2007). •• Discussions of the evolution of animal viruses as human pathogens. (Pubitemid 46788835)
97. Hahn BH, Shaw GM, De Cock KM, Sharp PM. AIDS as a zoonosis: scientific and public health implications. Science 287, 607-614 (2000).
98. Salemi M, Vandamme AM, Desmyter J, Casoli C, Bertazzoni U. The origin and evolution of human T-cell lymphotropic virus type II (HTLV-II) and the relationship with its replication strategy. Gene 234(1), 11-21 (1999). (Pubitemid 29291641)
99. Van Heuverswyn F, Peeters M. The origins of HIV and implications for the global epidemic. Curr. Infect. Dis. Rep. 9(4), 338-346 (2007). (Pubitemid 47162244)
100. Wain LV, Bailes E, Bibollet-Ruche F et al. Adaptation of HIV-1 to its human host. Mol. Biol. Evol. 24(8), 1853-1860 (2007). •• Signifies the generation of a human pathogenic retrovirus from simian origin.
101. Mahieux R, Ibrahim F, Mauclere P et al. Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-1 molecular subtype in central Africa and in Pygmies. J. Virol. 71(2), 1317-1333 (1997). (Pubitemid 27030306)
102. Slattery JP, Franchini G, Gessain A. Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses. Genome Res. 9(6), 525-540 (1999). (Pubitemid 29361269)
103. Marx PA, Apetrei C, Drucker E. AIDS as a zoonosis? Confusion over the origin of the virus and the origin of the epidemics. J. Med. Primatol. 33, 220-226 (2004). (Pubitemid 39378009)
104. Rosenberg N, Jolicoeur P. Retroviral Pathogenesis. Coffin JM, Hughes SH, Varmus HE (Eds). Cold Spring Harbor Laboratory Press, NY, USA (1997).
105. Bailes E, Gao F, Bibollet-Ruche F et al. Hybrid origin of SIV in chimpanzees. Science 300(5626), 1713 (2003).
106. Gartner K, Wiktorowicz T, Park J, Mergia A, Rethwilm A, Scheller C. Accuracy estimation of foamy virus genome copying. Retrovirology 6(1), 32 (2009).
107. Engel G, Hungerford LL, Jones-Engel L et al. Risk assessment: a model for predicting cross-species transmission of simian foamy virus from macaques (M. fascicularis) to humans at a monkey temple in Bali, Indonesia. Am. J. Primatol. 68(9), 934-948 (2006). (Pubitemid 44337985)
108. Boneva RS, Grindon AJ, Orton SL et al. Simian foamy virus infection in a blood donor. Transfusion 42(7), 886-891 (2002).
109. O'Brien SF, Yi QL, Fearon MA, Goldman M. A predonation screening question for occupational exposure to simian foamy virus: a preliminary donor survey in Canada. Transfusion 47(5), 949-950 (2007). (Pubitemid 46669016)
110. Schillaci M, Jones-Engel L, Engel G, Fuentes A. Characterizating the threat to the blood supply associated with nonoccupational exposure to emerging simian retroviruses. Transfusion 48, 398-401 (2008).
111. Allan JS. Understanding xenotransplantatoin risks from nonhuman primate retrovruses. Curr. Top. Microbiol. Immunol. 278, 101-123 (2003).
112. Apetrei CK, Lerche A, Metzger NW et al. Molecular epidemiology of simian immunodeficiency virus SIVsm in U.S. primate centers unravels the origin of SIVmac and SIVstm. J. Virol. 79, 8991-9005 (2005).
113. Gardner MB. The history of simian AIDS. J. Med. Primatol. 25(3), 148-157 (1996).
114. Allan JS. Cross-species infection: no news is good news? Nat. Med. 4, 644-645 (1998).
115. Lerche NW, Switzer WM, Yee JL et al. Evidence of infection with simian type D retrovirus in persons occupationally exposed to nonhuman primates. J. Virol. 75(4), 1783-1789 (2001).
116. Apetrei C, Marx PA. Simian retroviral infections in human beings. Lancet 364(9429), 137-138; author reply 139-140 (2004).
117. Wolfe ND, Switzer WM, Heneine W. Emergence of novel retroviruses. In: Emerging Infections. Scheld WM, Hooper DC, Hughes JM (Eds). ASM Press, DC, USA, 139-152 (2006).
118. Brown PO. Integration. In: Retroviruses. Coffin J, Hughes SH, Varmus H (Eds). Cold Spring Harbor Laboratory, NY, USA, 161-203 (1997).
119. Schweizer M, Schleer H, Pietrek M, Liegibel J, Falcone V, Neumann-Haefelin D. Genetic stability of foamy viruses: long-term study in an African green monkey population. J. Virol. 73(11), 9256-9265 (1999). (Pubitemid 29487081)
120. Butler IF, Pandrea I, Marx PA, Apetrei C. HIV genetic diversity: biological and public health consequences. Curr. HIV Res. 5(1), 23-45 (2007). (Pubitemid 46062357)
121. Oldstone MB. Viral persistence: parameters, mechanisms and future predictions. Virology 344(1), 111-118 (2006).
122. Levy JA. HIV pathogenesis: 25 years of progress and persistent challenges. AIDS 23(2), 147-160 (2009).
123. Ondoa P, Davis D, Kestens L et al. In vitro susceptibility to infection with SIVcpz and HIV-1 is lower in chimpanzee than in human peripheral blood mononuclear cells. J. Med. Primatol. 67, 301-311 (2002). (Pubitemid 34569066)
124. Liovat AS, Jacquelin B, Ploquin MJ, Barre-Sinoussi F, Muller-Trutwin MC. African nonhuman primates infected by SIV-why don't they get sick? Lessons from studies on the early phase of non-pathogenic SIV infection. Curr. HIV Res. 7, 39-50 (2009).
125. Xiong Y, Eickbush TH. Origin and evolution of retroelements based upon their reverse transcriptase sequences. EMBO J. 9(10), 3353-3362 (1990). (Pubitemid 20282550)
126. Mergia A, Shaw KE, Pratt-Lowe E, Barry PA, Luciw PA. Identification of the simian foamy virus transcriptional transactivator gene (taf ). J. Virol. 65(6), 2903-2909 (1991).
127. Lochelt M, Aboud M, Flugel RM. Increase in the basal transcriptional activity of the human foamy virus internal promoter by the homologous long terminal repeat promoter in cis. Nucleic Acids Res. 21(18), 4226-4230 (1993). (Pubitemid 23279010)
128. Lochelt M, Muranyi W, Flugel RM. Human foamy virus genome possesses an internal, Bel-1-dependent and functional promoter. Proc. Natl Acad. Sci. USA 90(15), 7317-7321 (1993). (Pubitemid 23222441)
129. Meiering CD, Rubio C, May C, Linial ML. Cell-type-specific regulation of the two foamy virus promoters. J. Virol. 75(14), 6547-6557 (2001). (Pubitemid 32578174)
130. Draft Guidance: characterization and qualification of cell substrates and other biological starting materials used in the production of viral vaccines for the prevention and treatment of infectious diseases. US Food Drug Administration (2006) www.fda.gov/cber/gdlns/vaccsubstrates.pdf
131. US FDA Blood Products Advisory Committee. Topic II: the potential risk of simian foamy virus tranmssion (monograph on the internet), Gaithersburg, MD (2004) www.fda.gov/ohrms/dockets/ac/cber04.html#BloodProducts